TLIK — Arzneiwerk VIDA AG Cashflow Statement
0.000.00%
- €2.07m
- €1.93m
- €0.21m
Annual cashflow statement for Arzneiwerk VIDA AG, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2020 December 31st | R2021 December 31st | C2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | GAS | IFRS | IFRS | IFRS | GAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 0.825 | -0.245 | -16.6 | -2.88 | -0.836 |
| Depreciation | |||||
| Non-Cash Items | -0.194 | 0.061 | 0.635 | 0.329 | -0.201 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | -1.64 | -0.04 | 0.591 | 1.73 | 0.175 |
| Change in Other Assets | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -0.986 | -0.203 | 1.13 | 0.194 | -0.855 |
| Capital Expenditures | -0.013 | -0.043 | -1.01 | -0.219 | 0 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | — | -0.03 | -0.091 | 0.005 | 0 |
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.013 | -0.073 | -1.1 | -0.214 | 0 |
| Financing Cash Flow Items | — | -0.022 | -0.284 | -0.556 | -0.233 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 1.74 | -0.084 | 1.07 | -1.17 | 0.899 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.738 | -0.36 | 1.1 | -1.19 | 0.043 |